Patents by Inventor Charalampos Tsirmpas

Charalampos Tsirmpas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240371398
    Abstract: A method includes, for each user in a population: audio recording the user reciting a story configured to elicit an emotion associated with a psychiatric condition; concurrently recording a set of biosignals of the user; generating a set of psychophysiological markers correlating instances of the emotion and the set of biosignals; assessing a clinical assessment for the condition in the user; correlating the set of psychophysiological markers and the clinical assessment; and compiling the correlations into a model configured to predict risk of condition onset in a user. The method also includes: accessing a series of biosignals of a first user; identifying a series of psychophysiological markers in the series of biosignals; based on the series of psychophysiological markers and the model, calculating a risk of onset of the condition in the first user; and, in response to the risk exceeding a threshold, serving the notification to the first user.
    Type: Application
    Filed: March 19, 2024
    Publication date: November 7, 2024
    Inventors: Georgios Eleftheriou, Panagiotis Fatouros, Charalampos Tsirmpas
  • Patent number: 11967339
    Abstract: A method includes: prompting a user to recite a story associated with a first target emotion; recording the user reciting the story and recording a first timeseries of biosignal data via a set of sensors integrated into a wearable device worn by the user; accessing a first timeseries of emotion markers extracted from the voice recording; labeling the first timeseries of biosignal data according to the first timeseries of emotion markers; generating an emotion model linking biosignals to emotion markers for the user based on the first emotion-labeled timeseries of biosignal data; detecting a second instance of the first target emotion exhibited by the user based on a second timeseries of biosignal data and the emotion model; and notifying the user of the second instance of the first target emotion.
    Type: Grant
    Filed: July 8, 2022
    Date of Patent: April 23, 2024
    Assignee: Feel Therapeutics Inc.
    Inventors: Georgios Eleftheriou, Panagiotis Fatouros, Charalampos Tsirmpas
  • Publication number: 20240062910
    Abstract: A method includes, during a first time, for each user in a population: accessing a clinical assessment for depression in the user; accessing a set of biosignal data of the user; deriving correlations between the set of biosignal data and the clinical assessment for depression; and compiling the correlations into a depression model configured to predict risk of future depression diagnosis. The method further includes, during a second time: accessing a series of biosignal data collected by a device worn by a first user; accessing a target duration; calculating a risk of presentation of depression symptoms by the first user within the target duration based on the series of biosignal data; and in response to the risk exceeding a threshold, serving a notification to a care provider associated with the first user, the notification indicating the risk and including a prompt to investigate the first user for treatment.
    Type: Application
    Filed: August 18, 2023
    Publication date: February 22, 2024
    Inventors: Georgios Eleftheriou, Panagiotis Fatouros, Charalampos Tsirmpas
  • Publication number: 20230301586
    Abstract: One variation of a method includes: accessing a first timeseries of biosignal data collected by a wearable device worn by a user during a first time period; deriving a first insomnia profile, representative of a set of health indicators exhibited by the user during the first time period, based on the first timeseries of biosignal data; and selecting a treatment pathway for implementation by the user based on the first insomnia profile. The method further includes: accessing a second timeseries of biosignal data collected for the user by the wearable device during a second time period; deriving a second insomnia profile, representative of the set of health indicators exhibited by the user during the second time period, based on the second timeseries of biosignal data; and characterizing effectiveness of the treatment pathway based on a difference between the first insomnia profile and the second insomnia profile.
    Type: Application
    Filed: March 24, 2023
    Publication date: September 28, 2023
    Inventors: Georgios Eleftheriou, Panagiotis Fatouros, Charalampos Tsirmpas
  • Publication number: 20220343941
    Abstract: A method includes: prompting a user to recite a story associated with a first target emotion; recording the user reciting the story and recording a first timeseries of biosignal data via a set of sensors integrated into a wearable device worn by the user; accessing a first timeseries of emotion markers extracted from the voice recording; labeling the first timeseries of biosignal data according to the first timeseries of emotion markers; generating an emotion model linking biosignals to emotion markers for the user based on the first emotion-labeled timeseries of biosignal data; detecting a second instance of the first target emotion exhibited by the user based on a second timeseries of biosignal data and the emotion model; and notifying the user of the second instance of the first target emotion.
    Type: Application
    Filed: July 8, 2022
    Publication date: October 27, 2022
    Inventors: Georgios Eleftheriou, Panagiotis Fatouros, Charalampos Tsirmpas
  • Patent number: 11410682
    Abstract: A method includes: prompting a user to recite a story associated with a first target emotion; recording the user reciting the story and recording a first timeseries of biosignal data via a set of sensors integrated into a wearable device worn by the user; accessing a first timeseries of emotion markers extracted from the voice recording; labeling the first timeseries of biosignal data according to the first timeseries of emotion markers; generating an emotion model linking biosignals to emotion markers for the user based on the first emotion-labeled timeseries of biosignal data; detecting a second instance of the first target emotion exhibited by the user based on a second timeseries of biosignal data and the emotion model; and notifying the user of the second instance of the first target emotion.
    Type: Grant
    Filed: July 2, 2019
    Date of Patent: August 9, 2022
    Assignee: Sentio Solutions, Inc.
    Inventors: Georgios Eleftheriou, Panagiotis Fatouros, Charalampos Tsirmpas
  • Publication number: 20220061726
    Abstract: One variation of a method for characterizing ADHD includes: accessing results of a cognitive evaluation executed by a user; accessing a timeseries of biosignal data collected via sensors worn by the user during execution of the cognitive evaluation; accessing a global model linking results of the cognitive evaluation and biosignal data to cognitive states of users diagnosed with ADHD; and interpreting a confidence score, representing probability of an ADHD diagnosis, based on results of the cognitive evaluation, the timeseries of biosignal data, and the global model. The method further includes, in response to the confidence score exceeding a threshold confidence: selecting a treatment pathway for the user based on results of the cognitive evaluation and the timeseries of biosignal data; and deriving an ADHD model for the user linking biosignal data to cognitive states based on results of the cognitive evaluation, the timeseries of biosignal data, and the global model.
    Type: Application
    Filed: August 30, 2021
    Publication date: March 3, 2022
    Inventors: Georgios Eleftheriou, Panagiotis Fatouros, Charalampos Tsirmpas
  • Publication number: 20200075039
    Abstract: A method includes: prompting a user to recite a story associated with a first target emotion; recording the user reciting the story and recording a first timeseries of biosignal data via a set of sensors integrated into a wearable device worn by the user; accessing a first timeseries of emotion markers extracted from the voice recording; labeling the first timeseries of biosignal data according to the first timeseries of emotion markers; generating an emotion model linking biosignals to emotion markers for the user based on the first emotion-labeled timeseries of biosignal data; detecting a second instance of the first target emotion exhibited by the user based on a second timeseries of biosignal data and the emotion model; and notifying the user of the second instance of the first target emotion.
    Type: Application
    Filed: July 2, 2019
    Publication date: March 5, 2020
    Inventors: Georgios Eleftheriou, Panagiotis Fatouros, Charalampos Tsirmpas
  • Publication number: 20180014739
    Abstract: One variation of a system for unobtrusively recognizing emotions of users includes: a galvanic skin response sensor; a heart rate sensor; a skin temperature sensor; a motion sensor; and a controller configured to sample a sequence of biosignal values of a user from the galvanic skin response sensor, the heart rate sensor, the skin temperature sensor, and the motion sensor, to implement statistical tests, self-organising maps, and clustering techniques to identify of significant changes in characteristics of the sequence of biosignal values, and to predict an emotional status of the user based on the significant changes in characteristics of the sequence of biosignal values.
    Type: Application
    Filed: July 13, 2017
    Publication date: January 18, 2018
    Inventors: Georgios Eleftheriou, Panagiotis Fatouros, Charalampos Tsirmpas